About

Verily Life Sciences is an Alphabet company dedicated to precision health. They develop tools and solutions to collect and organize health data, generate evidence, and apply insights to prevent, detect, and manage disease. Their strategy involves leveraging technology and data science to transform healthcare.

Key facts

At-a-glance profile data

Website: verily.com
Headquarters: South San Francisco, USA
Portfolio companies: 4
Stages: Series A
Cheque size: $40M to $100M
Sector focus: Life Sciences
Healthcare Technology
Biotechnology
Digital Health
Medical Devices

Recent investments

Recent funding rounds Verily took part in
Date	Company	Round	Amount
25 Apr 2022	Syllable	Series C	$40M
3 Feb 2021	Freenome	Series D	$300M
19 Aug 2020	Freenome	Series C	$270M
30 Jan 2020	Mammoth Biosciences	Series B	$45M
31 May 2018	Insitro	Series A	$100M

Add first review

Frequently asked

What companies has Verily invested in?

Verily has invested in Syllable, Freenome, Mammoth Biosciences, Insitro.